Dear Researchers,

The 2018 grant application process will reopen in November 2018. Grant applications will include 1.) our overall grant program for pediatric brain tumors at $30,000 per year for up to two-years; and 2.) applications for pediatric glioblastoma multiforme ($45,000 one-year).  We look forward to posting the application process in the fall.

Family Adjustment and Coping:  Models & Challenges

Lisa Jacobson, Ph.D., CN, ABPP
Kennedy Krieger Institute
Johns Hopkins School of Medicine

Tackling school challenges in survivors of pediatric brain tumors:  Learning tools and strategies for the 21st century

Kristina Hardy, M.D.
Children’s National Health System

Childhood Brain Tumors: Challenges Ahead

Roger J. Packer, M.D. (Morning Keynote Speaker)
Senior Vice-President Neuroscience and Behavioral Medicine
Director, Brain Tumor Institute, Director, Gilbert Family Neurofibromatosis Institute
Children’s National Health System


The Neurotransmitter is a semi-annual newsletter published by The Childhood Brain Tumor Foundation.

In this issue:

2016 Casino Gala

Board of Directors

Spring 2017 Events

...and more!

Kirsten Baker is the Managing Director at PRISM. Kirsten manages PRISM's largest commercial account and promotes the development of other internal hires.  She recruits, hires, trains and mentors new Recruiting and Sales team members and work with referral networks, continuing to launch careers in creative, technical, niche, executive and other in-demand skill areas. Contributes to employer branding, strategy and brainstorm sessions.

Eva B. Perdahl Wallace, MD, hematology and Oncology, Kaiser Permanente Capitol Hill, is a practicing Pediatric Hematologist-Oncologist in Washington, DC.  Dr. Perdahl-Wallace graduated from Umea University in 1981 and has been in practice for 34 years. She completed a residency at Beth Israel Medical Center. Dr. Perdahl-Wallace also specializes in Pediatrics. She previously practiced at Children's National Medical Center Surgery and an affiliation with Children's Hospital of The King's Daughter and Inova Fairfax Hospital.

Dr. Cheng-Ying Ho, Assistant Professor of Pathology at University of Maryland School of Medicine, has a research focus on the molecular mechanisms underlying the development and regeneration of cutaneous mechanosensory neurons.

Dr. Charles Eberhart, professor of pathology and oncology is an associate professor of ophthalmology, at The Johns Hopkins University School of Medicine. His research interests primarily focus on molecular genetics and treatment of medulloblastoma, glioblastoma, uveal melanoma and other tumors of the brain and eye. Dr. Eberhart serves as director of the Divisions of Neuropathology and Ophthalmic Pathology.

The Neurotransmitter is a semi-annual newsletter published by The Childhood Brain Tumor Foundation.

In this issue:

2016 Grants

2016 Superheroes 5K & Kids' Fun Run

Special Thanks and Remembrances

Research Summaries

...and more!

Page 1 of 9

Thanks to Our Sponsors